Non‐Invasive Diagnosis of Moyamoya Disease Using Serum Metabolic Fingerprints and Machine Learning
Advanced Science · 2025-02 · 12 (8)
DOI: 10.1002/advs.202405580 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 31.12.2024. Verfasst von Ruiyuan Weng und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Huashan Hospital of Fudan University, Shanghai, 200040, P. R. China. Hauptthemen laut MEDLINE: Moyamoya Disease, Machine Learning. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Ministry of Science and Technology, Medical-Engineering Joint Funds of Shanghai Jiao Tong University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Moyamoya disease (MMD) is a progressive cerebrovascular disorder that increases the risk of intracranial ischemia and hemorrhage. Timely diagnosis and intervention can significantly reduce the risk of new‐onset stroke in patients with MMD. However, the current diagnostic methods are invasive and expensive, and non‐invasive diagnosis using biomarkers of MMD is rarely reported. To address this issue, nanoparticle‐enhanced laser desorption/ionization mass spectrometry (LDI MS) was employed to record serum metabolic fingerprints (SMFs) with the aim of establishing a non‐invasive diagnosis method for MMD. Subsequently, a diagnostic model was developed based on deep learning algorithms, which exhibited high accuracy in differentiating the MMD group from the HC group (AUC = 0.958, 95% CI of 0.911 to 1.000). Additionally, hierarchical clustering analysis revealed a significant association between SMFs across different groups and vascular cognitive impairment in MMD. This approach holds promise as a novel and intuitive diagnostic method for MMD. Furthermore, the study may have broader implications for the diagnosis of other neurological disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Huashan Hospital of Fudan University, Shanghai, 200040, P. R. China.
- Neurosurgical Institute of Fudan University, Shanghai, 201107, P. R. China.
- Department of Traditional Chinese Medicine, RenJi Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
- School of Biomedical Engineering, Institute of Medical Robotics and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, 200030, P. R. China.
- State Key Laboratory for Oncogenes and Related Genes, Division of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, P. R. China.
- Department of Neurosurgery, Liaocheng People's Hospital, Shandong, 252000, China.
Förderung
- National Ministry of Science and Technology
- Medical-Engineering Joint Funds of Shanghai Jiao Tong University
- National Natural Science Foundation of China
- Innovative Research Team of High-Level Local Universities in Shanghai
- Innovation Research Plan by the Shanghai Municipal Education Commission
- National High Level Hospital Clinical Research Funding
- Shanghai Institutions of Higher Learning
- Sichuan Provincial Department of Science and Technology
Zitieren
APA
Weng, R., Xu, Y., Gao, X., Cao, L., Su, J., Yang, H., Li, H., Ding, C., Pu, J., Zhang, M., Hao, J., Xu, W., Ni, W., Qian, K., & Gu, Y. (2025). Non‐Invasive Diagnosis of Moyamoya Disease Using Serum Metabolic Fingerprints and Machine Learning. Advanced Science, 12(8). https://doi.org/10.1002/advs.202405580
Vancouver
Weng R, Xu Y, Gao X, Cao L, Su J, Yang H, et al. Non‐Invasive Diagnosis of Moyamoya Disease Using Serum Metabolic Fingerprints and Machine Learning. Advanced Science. 2025;12(8). doi:10.1002/advs.202405580
BibTeX
@article{Weng2025,
author = {Weng, Ruiyuan and Xu, Yudian and Gao, Xinjie and Cao, Linlin and Su, Jiabin and Yang, Heng and Li, He and Ding, Chenhuan and Pu, Jun and Zhang, Meng and Hao, Jiheng and Xu, Wei and Ni, Wei and Qian, Kun and Gu, Yuxiang},
title = {Non‐Invasive Diagnosis of Moyamoya Disease Using Serum Metabolic Fingerprints and Machine Learning},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {8},
doi = {10.1002/advs.202405580}
}
EUVIMED